Gut microbiota: A new target of traditional Chinese medicine for insomnia - 26/02/23
, Zhihua Yang a, b, 1 , Yangxi Liu c , Rui Chen d , Zhihui Song a, b , Guiyun Pan a, b , Yuhang Zhang a, b , Zehui Guo a, b , Xinya Ding c , Lu Chen a, b, ⁎ , Yi Wang a, b, ⁎ Abstract |
All species have a physiological need for sleep, and sleep is crucial for the preservation and restoration of many physiological processes in the body. Recent research on the effects of gut microbiota on brain function has produced essential data on the relationship between them. It has been discovered that dysregulation of the gut-brain axis is related to insomnia. Certain metabolites of gut microbiota have been linked to insomnia, and disturbances in gut microbiota can worsen insomnia. Traditional Chinese medicine (TCM) has unique advantages for the treatment of insomnia. Taking the gut microbiota as the target and determining the scientific relevance of TCM to the prevention and treatment of insomnia may lead to new concepts for the treatment of sleep disorders and improve the therapeutic effect of sleep. Taking the gut microbiota as an entry point, this paper reviews the relationship between gut microbiota and TCM, the relationship between gut microbiota and insomnia, the mechanism by which gut microbiota regulate sleep, and the mechanism by which TCM regulates gut microbiota for insomnia prevention and treatment. This review provides new ideas for the prevention and treatment of insomnia through TCM and new ideas for drug development.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | Traditional Chinese medicine has unique advantages in the treatment of insomnia. |
• | The imbalance of gut microbiota is closely related to insomnia. |
• | Traditional Chinese medicine can treat insomnia by regulating gut microbiota. |
Abbreviations : TCM, RCTs, GGLMD, LPS, BGM, IL-1β, IL-6, IL-7, TNF-α, NF-κB, CRF, ACTH, GABA, CNS, 5-HT, NREM, WSC, BLM, RPE, HPA, SCFAs, Th17, GF mice, ZSS
Keywords : Insomnia, Gut microbiota, Traditional Chinese medicine, Brain-gut-microbiota axis
Plan
Vol 160
Article 114344- avril 2023 Retour au numéro
Article précédent
- SOX2-associated signaling pathways regulate biological phenotypes of cancers
- L.N. Ding, Y.Y. Yu, C.J. Ma, C.J. Lei, H.B. Zhang
- The pharmacological and biological importance of EZH2 signaling in lung cancer
- Maliheh Entezari, Afshin Taheriazam, Mahshid Deldar Abad Paskeh, Eisa Sabouni, Mohammad Arad Zandieh, Maryam Aboutalebi, Amirabbas Kakavand, Shamin Rezaei, Elahe Sadat Hejazi, Hamidreza Saebfar, Shokooh Salimimoghadam, Sepideh Mirzaei, Mehrdad Hashemi, Saeed Samarghandian
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?